Taking TRT and PDE5 Inhibitors Together: What the Evidence Says About Combination Therapy for Low T + ED

When you have both low testosterone and erectile dysfunction, treating just one often isn't enough. Here's why combination therapy works — and how to do it right.

Published March 19, 2026 · MenRxFast Editorial Team

If you have both low testosterone and erectile dysfunction, you've probably noticed something frustrating: Viagra or Cialis helps, but not as much as you expected. Or TRT improved your energy and libido, but erections still aren't where they should be.

You're not imagining it. Low testosterone and ED have overlapping but distinct mechanisms, and treating one without addressing the other often leaves men stuck in a partial-improvement zone. The clinical evidence increasingly supports what many men discover intuitively: combination therapy — TRT plus a PDE5 inhibitor — works substantially better than either alone.

Why Either Treatment Alone Often Falls Short

To understand why combination therapy works, it helps to understand why each treatment alone has limitations.

PDE5 inhibitors (Viagra, Cialis, Levitra) work by blocking the enzyme that breaks down cGMP, a molecule that relaxes smooth muscle in the penis and allows blood flow. They're essentially amplifiers — they enhance the erectile response to sexual stimulation. But they depend on a signal to amplify. If testosterone is low, the upstream signals (desire, arousal, nitric oxide release) are weakened. You're turning up the volume on a signal that's already faint.

TRT addresses the hormonal component: it restores desire, improves nitric oxide synthase expression, enhances nerve sensitivity, and improves the vascular endothelium. But for men with long-standing ED — especially those with vascular damage from diabetes, hypertension, or smoking — hormonal restoration alone may not overcome the structural and vascular factors limiting blood flow.

In other words: TRT fixes the signal, and PDE5 inhibitors amplify it. Together, they cover both halves of the equation.

The Clinical Evidence for Combination Therapy

The most-cited study comes from Columbia University, where researchers found that men on TRT plus sildenafil experienced a 34% improvement in erectile function scores, compared to just 17% for sildenafil alone. That's double the benefit.

Additional research supports this pattern:

The "rescue" effect is particularly important. If you've been prescribed Viagra or Cialis and found them disappointing, the problem may not be the drug — it may be that your hormonal foundation isn't supporting the drug's mechanism. Checking testosterone levels before writing off PDE5 inhibitors is one of the most underutilized steps in ED management.

How to Approach Combination Therapy in Practice

Step 1: Get Baseline Labs

Before combining treatments, you need clear data. At minimum: total testosterone, free testosterone, estradiol, SHBG, and a basic metabolic panel. If testosterone is genuinely low (below 300 ng/dL total, or low free testosterone for age), the hormonal component of your ED has a clear driver. Our blood panel guide covers exactly what to test and why.

Step 2: Start TRT (or Alternative) and Stabilize

Most protocols allow 6–12 weeks for TRT to reach steady-state blood levels and for the downstream effects on libido, nitric oxide, and endothelial function to manifest. Some men find that ED resolves during this period without needing a PDE5 inhibitor at all. For a comprehensive overview of TRT protocols and providers, TrueTRT is the dedicated resource.

Providers like Feel30 offer monitored TRT with regular blood work, and MangoRx provides TRT alongside their ED offerings — meaning your prescribing physician can coordinate both treatments on a single platform.

Step 3: Add PDE5 Inhibitor for Residual ED

If ED persists after testosterone levels have normalized (and been confirmed by follow-up labs), adding a PDE5 inhibitor is the logical next step. The most common options:

Daily low-dose tadalafil (2.5–5mg) is increasingly popular in combination protocols because it provides consistent baseline support rather than requiring timing around sexual activity.

BraveRX offers ED prescriptions through telehealth consultations, and EDPillGuide compares pricing and formulations across all major providers.

Safety Considerations

The combination of TRT and PDE5 inhibitors is generally well-tolerated and widely prescribed. There are no known dangerous interactions between testosterone and sildenafil, tadalafil, or vardenafil. However, monitoring requirements increase with combination therapy:

When Combination Therapy Isn't Enough

For most men with both low T and ED, TRT plus a PDE5 inhibitor is sufficient. But a subset — particularly men with severe vascular ED from diabetes or long-standing cardiovascular disease — may need escalation beyond oral medications.

The treatment ladder beyond PDE5 inhibitors includes penile injection therapy (trimix), vacuum erection devices, and penile prosthesis as a definitive surgical option. Our article on when ED pills stop working covers the full escalation pathway.

The Bottom Line

If you have both low testosterone and ED, treating only one condition is like fixing half a broken bridge. The clinical data is clear: combination therapy produces roughly double the improvement of either treatment alone, and adding TRT can "rescue" men who didn't respond adequately to PDE5 inhibitors on their own.

The practical approach: start with blood work, address the hormonal component first (TRT or alternatives like enclomiphene), allow time to stabilize, and add a PDE5 inhibitor for residual ED if needed. Platforms like MangoRx that offer both TRT and ED treatment on a single platform make coordination easier.

For the full protocol on sequencing men's health treatments, including where combination therapy fits in the broader picture, see our complete optimization protocol.